Litcius/Paper detail

Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategy

Ketki Bhise, Navnath S. Gavande, Arun K. Iyer

2023Drug Discovery Today10 citationsDOI

Topics & Concepts

Triple-negative breast cancerTaxaneMedicineBreast cancerChemotherapyOncologyPARP inhibitorRegimenImmunotherapyInternal medicineCancer researchCancerPoly ADP ribose polymeraseBiologyPolymeraseGeneBiochemistryCancer, Hypoxia, and MetabolismNanoplatforms for cancer theranosticsCancer Immunotherapy and Biomarkers
Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategy | Litcius